Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list
A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's tirzepatide from an official shortages list.
Lilly Weight-Loss Drug Copycat Makers Sue FDA Over Shortage End
A group representing companies that made copycat versions of Eli Lilly & Co.’s weight-loss drugs sued the US Food and Drug Administration over the agency’s decision to remove Lilly’s medications from its shortage list.
Compounding Group Sues FDA for Removing Lilly's Weight Loss Drug From Shortage List
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s blockbuster weight loss and diabetes drugs from its shortage list last week,
Trade group sues FDA for removing Lilly weight-loss drug from shortage list
A group representing companies that produce copycat versions of Eli Lilly weight loss medications has filed a lawsuit against the FDA following the agency's recent decision to remove the drug's from its shortage list,
Eli Lilly obesity drug shortage ends fueling lawsuit against FDA
A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) weight loss drug tirzepatide. Read more here.
12h
on MSN
Is the U.S. at a Turning Point on Obesity?
An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.
2h
Takeaway hours plan fails to curb child obesity
A plan to restrict the opening hours of fast food outlets near schools has failed to curb childhood obesity, with rates ...
18h
on MSN
WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program
WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...
BioSpace
2h
Lilly’s Sprawling Obesity Clinical Program Underscores Challenges for Biotechs
Eli Lilly’s CEO David Ricks is confident his company and peer Novo Nordisk are years ahead in the weight loss space, as ...
4d
on MSN
Obesity in the U.S. Is Finally Declining. You Can (Probably) Thank Ozempic.
"Americans are fat and getting fatter," wrote Reason's Ron Bailey in a March 2023 piece about obesity and the hope such ...
Medscape
18h
How Are Ultra-Processed Foods Fueling the Obesity Epidemic?
Consumption of UPFs increased body weight and energy intake in overweight and obese young men, found a small study ...
4h
Obesity medicines would cost US medicare $35 billion through 2034
Expanding coverage of weight-loss drugs like blockbusters from Eli Lilly & Co. and Novo Nordisk A/S would make 12.5 million ...
1d
Obesity Drugmaker Rivus Said to Weigh IPO as Soon as This Year
Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as ...
12d
How the US obesity rate has evolved over the past decade, explained in charts
At least 1 in 5 adults in each U.S. state live with obesity, new data from the Centers for Disease Control and Prevention ...
1d
Good mental health at 11 'cuts later obesity risk'
Researchers suggest age 11 "may be a sensitive period in which psychological wellbeing is associated with future body weight" ...
Opinion
8d
Opinion
How Should We View and Treat Obesity?
Readers discuss an essay about whether it is a disease and how it should be diagnosed. Also: Fear in schools; natural ...
4h
on MSN
More smoking, more obesity, more sleep medication use - report
The report shows a rise in medication use, obesity, and smoking, a decline in cancer screenings, concerns over excessive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly
Artificial intelligence
COVID-19
United States
Food and Drug Administration
Feedback